RCUS Competitors & Alternatives
Compare Arcus Biosciences Inc with similar stocks in the same industry
Biotechnology
RCUS
Main Stock$18.29
Tradestie Score
61
Market Cap
$1.43B
Revenue Growth
-0.7%
Analyst Upside
+124.2%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$16.59
|
$2.89B | - | 41 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$35.43
|
$2.85B | - | 37 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 51 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$24.94
|
$2.44B | - | 45 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$77.17
|
$2.42B | - | 54 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$166.00
|
$2.41B | - | 45 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$31.71
|
$2.40B | - | 60 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
More RCUS Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry